ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

ClinicalTrials.gov ID: NCT06260891

Public ClinicalTrials.gov record NCT06260891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 11:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06260891
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of California, San Francisco
Other
Enrollment
34 participants

Conditions and interventions

Interventions

  • 25 mg/day zinc Drug
  • 40 mg/day zinc Drug

Drug

Eligibility (public fields only)

Age range
15 Years to 40 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 13, 2026
Primary completion
Jul 30, 2027
Completion
Dec 30, 2027
Last update posted
Mar 12, 2026

2026 – 2027

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
UCSF Benioff Children's Hospital Oakland Oakland California 94609 Recruiting
Duke University Medical Center Durham North Carolina 27710 Not yet recruiting
Cincinnati Children's Hospital Cincinnati Ohio 45229 Not yet recruiting
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 Not yet recruiting
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 Not yet recruiting
Baylor College of Medicine Houston Texas 77030 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06260891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06260891 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →